XFOR X4 Pharmaceuticals, Inc
Nasdaq · SEC CIK 1501697 · EDGAR
- Bought, last 12 months
- $250.0K 1 purchases by 1 insiders
- Sold, last 12 months
- $429.3K 4 sales by 3 insiders
- Filings on record
- 150 since 2021-07-01, latest 2026-08-13 16:13
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Craig Adam R | Executive COB, Dir | $250.0K | $210.8K |
| KIRSKE DAVID | CFO | — | $109.2K |
| Volpone John | Pres | — | $109.2K |
Transactions 140
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-19 | 2022-08-17 | XFOR | Ragan Paula | Pres, CEO, Dir | S - Sale | — | -13.4K | 634.9K | -2% | — | |
| 2022-08-19 | 2022-08-17 | XFOR | DiBiase Mary | COO | S - Sale | — | -1,713 | 177.9K | -1.0% | — | |
| 2022-08-19 | 2022-08-17 | XFOR | Meisner Derek M | CLO | S - Sale | — | -8,334 | 145.2K | -5% | — | |
| 2022-08-19 | 2022-08-17 | XFOR | Mostafa Adam S. | CFO | S - Sale | — | -10.8K | 173.9K | -6% | — | |
| 2022-07-01 | 2022-06-30 | XFOR | DiBiase Mary | COO | S - Sale | — | -1,578 | 179.6K | -0.9% | — | |
| 2022-07-01 | 2022-06-30 | XFOR | Mostafa Adam S. | CFO | S - Sale | — | -2,641 | 184.8K | -1% | — | |
| 2022-06-27 | 2022-06-24 | XFOR | Mostafa Adam S. | CFO | S - Sale | — | -5,416 | 187.4K | -3% | — | |
| 2022-06-27 | 2022-06-06 | XFOR | Stewart Murray | Dir | A - Grant | $0.00 | +6,667 | 6,667 | New | $0 | |
| 2022-06-27 | 2022-06-06 | XFOR | Bridger Gary | Dir | A - Grant | $0.00 | +6,667 | 6,667 | New | $0 | |
| 2022-06-27 | 2022-06-06 | XFOR | Aliski William | Dir | A - Grant | $0.00 | +6,667 | 6,667 | New | $0 | |
| 2022-06-27 | 2022-06-24 | XFOR | DiBiase Mary | COO | S - Sale | — | -856 | 181.2K | -0.5% | — | |
| 2022-06-27 | 2022-06-24 | XFOR | Ragan Paula | Pres, CEO, Dir | S - Sale | — | -6,724 | 648.4K | -1% | — | |
| 2022-06-27 | 2022-06-24 | XFOR | Meisner Derek M | CLO | S - Sale | — | -4,166 | 153.5K | -3% | — | |
| 2022-06-27 | 2022-06-06 | XFOR | Lawton Alison Frances | Dir | A - Grant | $0.00 | +6,667 | 6,667 | New | $0 | |
| 2022-06-27 | 2022-06-06 | XFOR | WYZGA MICHAEL S | Dir | A - Grant | $0.00 | +6,667 | 6,667 | New | $0 | |
| 2022-06-27 | 2022-06-06 | XFOR | de Craecker Francoise | Dir | A - Grant | $0.00 | +6,667 | 6,667 | New | $0 | |
| 2022-06-27 | 2022-06-06 | XFOR | MCGIRR DAVID W J | Dir | A - Grant | $0.00 | +6,667 | 6,667 | New | $0 | |
| 2022-06-17 | 2022-06-16 | XFOR | Ragan Paula | Pres, CEO, Dir | S - Sale | — | -6,724 | 655.1K | -1% | — | |
| 2022-06-17 | 2022-06-16 | XFOR | DiBiase Mary | COO | S - Sale | — | -856 | 182.0K | -0.5% | — | |
| 2022-06-17 | 2022-06-16 | XFOR | Mostafa Adam S. | CFO | S - Sale | — | -5,416 | 192.8K | -3% | — | |
| 2022-06-17 | 2022-06-16 | XFOR | Meisner Derek M | CLO | S - Sale | — | -4,166 | 157.7K | -3% | — | |
| 2022-06-06 | 2022-06-03 | XFOR | Ragan Paula | Pres, CEO, Dir | S - Sale | $1.21 | -6,292 | 661.8K | -0.9% | -$7,613 | |
| 2022-03-01 | 2022-03-01 | XFOR | Ragan Paula | Pres, CEO, Dir | A - Grant | $0.00 | +220.8K | 668.1K | +49% | $0 | |
| 2022-03-01 | 2022-03-01 | XFOR | Cadavid Diego | Chief Medical Off | A - Grant | $0.00 | +97.0K | 104.1K | +1,365% | $0 | |
| 2022-03-01 | 2022-03-01 | XFOR | Taveras Arthur | CSO | A - Grant | $0.00 | +97.0K | 104.1K | +1,365% | $0 | |
| 2022-03-01 | 2022-03-01 | XFOR | Meisner Derek M | CLO | A - Grant | $0.00 | +105.0K | 161.8K | +185% | $0 | |
| 2022-03-01 | 2022-03-01 | XFOR | Mostafa Adam S. | CFO | A - Grant | $0.00 | +105.0K | 198.2K | +113% | $0 | |
| 2022-03-01 | 2022-03-01 | XFOR | DiBiase Mary | COO | A - Grant | $0.00 | +105.0K | 182.9K | +135% | $0 | |
| 2022-02-14 | 2022-02-11 | XFOR | DiBiase Mary | COO | S - Sale | — | -12.5K | 77.9K | -14% | — | |
| 2022-02-14 | 2022-02-11 | XFOR | Taveras Arthur | CSO | F - Tax | $0.00 | -928 | 7,107 | -12% | $0 | |
| 2022-02-14 | 2022-02-11 | XFOR | Meisner Derek M | CLO | S - Sale | — | -15.9K | 56.8K | -22% | — | |
| 2022-02-14 | 2022-02-11 | XFOR | Cadavid Diego | Chief Medical Off | S - Sale | — | -928 | 7,107 | -12% | — | |
| 2022-02-14 | 2022-02-11 | XFOR | Ragan Paula | Pres, CEO, Dir | S - Sale | — | -21.7K | 447.3K | -5% | — | |
| 2022-02-14 | 2022-02-11 | XFOR | Mostafa Adam S. | CFO | S - Sale | — | -27.7K | 93.2K | -23% | — | |
| 2021-09-10 | 2021-09-08 | XFOR | DiBiase Mary | COO | A - Grant | $0.00 | +27.0K | 90.4K | +43% | $0 | |
| 2021-08-19 | 2021-08-17 | XFOR | Mostafa Adam S. | CFO | S - Sale | $5.10 | -10.8K | 120.9K | -8% | -$55.2K | |
| 2021-08-19 | 2021-08-17 | XFOR | Ragan Paula | Pres, CEO, Dir | S - Sale | $5.10 | -13.4K | 469.0K | -3% | -$68.6K | |
| 2021-08-19 | 2021-08-17 | XFOR | Meisner Derek M | GC | S - Sale | $5.10 | -8,332 | 72.7K | -10% | -$42.5K | |
| 2021-07-16 | 2021-07-15 | XFOR | Ragan Paula | Pres, CEO, Dir | S - Sale | $5.78 | -13.4K | 482.5K | -3% | -$77.7K | |
| 2021-07-01 | 2021-06-30 | XFOR | Mostafa Adam S. | CFO | S - Sale | $6.64 | -2,641 | 131.8K | -2% | -$17.5K |
Purchase Sale Sale after option exercise All abbreviations